Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
Department of Statistics, Seoul National University, Seoul, South Korea4currently with ASAN Medical Center, Seoul, South Korea.
JAMA Surg. 2014 Mar;149(3):275-87. doi: 10.1001/jamasurg.2013.3654.
The prevalence of obesity and outcomes of bariatric surgery are well established. However, analyses of the surgery impact have not been updated and comprehensively investigated since 2003.
To examine the effectiveness and risks of bariatric surgery using up-to-date, comprehensive data and appropriate meta-analytic techniques.
Literature searches of Medline, Embase, Scopus, Current Contents, Cochrane Library, and Clinicaltrials.gov between 2003 and 2012 were performed.
Exclusion criteria included publication of abstracts only, case reports, letters, comments, or reviews; animal studies; languages other than English; duplicate studies; no surgical intervention; and no population of interest. Inclusion criteria were a report of surgical procedure performed and at least 1 outcome of interest resulting from the studied surgery was reported: comorbidities, mortality, complications, reoperations, or weight loss. Of the 25,060 initially identified articles, 24,023 studies met the exclusion criteria, and 259 met the inclusion criteria.
A review protocol was followed throughout. Three reviewers independently reviewed studies, abstracted data, and resolved disagreements by consensus. Studies were evaluated for quality.
Mortality, complications, reoperations, weight loss, and remission of obesity-related diseases.
A total of 164 studies were included (37 randomized clinical trials and 127 observational studies). Analyses included 161,756 patients with a mean age of 44.56 years and body mass index of 45.62. We conducted random-effects and fixed-effect meta-analyses and meta-regression. In randomized clinical trials, the mortality rate within 30 days was 0.08% (95% CI, 0.01%-0.24%); the mortality rate after 30 days was 0.31% (95% CI, 0.01%-0.75%). Body mass index loss at 5 years postsurgery was 12 to 17. The complication rate was 17% (95% CI, 11%-23%), and the reoperation rate was 7% (95% CI, 3%-12%). Gastric bypass was more effective in weight loss but associated with more complications. Adjustable gastric banding had lower mortality and complication rates; yet, the reoperation rate was higher and weight loss was less substantial than gastric bypass. Sleeve gastrectomy appeared to be more effective in weight loss than adjustable gastric banding and comparable with gastric bypass.
Bariatric surgery provides substantial and sustained effects on weight loss and ameliorates obesity-attributable comorbidities in the majority of bariatric patients, although risks of complication, reoperation, and death exist. Death rates were lower than those reported in previous meta-analyses.
肥胖症的流行和减重手术的结果已经得到充分证实。然而,自 2003 年以来,尚未对手术的影响进行更新和全面的分析。
使用最新的、全面的数据和适当的荟萃分析技术,检查减重手术的有效性和风险。
对 2003 年至 2012 年间的 Medline、Embase、Scopus、Current Contents、Cochrane Library 和 Clinicaltrials.gov 进行了文献检索。
排除标准包括仅发表摘要、病例报告、信件、评论或综述、动物研究、非英语语言、重复研究、无手术干预以及无感兴趣的人群。纳入标准为报告了手术程序,并且至少报告了研究手术的一个感兴趣的结果:合并症、死亡率、并发症、再次手术或体重减轻。在最初确定的 25060 篇文章中,24023 篇研究符合排除标准,259 篇符合纳入标准。
整个过程都遵循了审查方案。三名审查员独立审查研究,提取数据,并通过协商解决分歧。研究的质量进行了评估。
死亡率、并发症、再次手术、体重减轻和肥胖相关疾病的缓解。
共纳入 164 项研究(37 项随机临床试验和 127 项观察性研究)。分析包括 161756 名平均年龄为 44.56 岁、体重指数为 45.62 的患者。我们进行了随机效应和固定效应荟萃分析和荟萃回归。在随机临床试验中,术后 30 天内的死亡率为 0.08%(95%CI,0.01%-0.24%);术后 30 天的死亡率为 0.31%(95%CI,0.01%-0.75%)。术后 5 年体重指数丢失 12-17。并发症发生率为 17%(95%CI,11%-23%),再次手术率为 7%(95%CI,3%-12%)。胃旁路术在体重减轻方面更有效,但与更多的并发症相关。可调胃束带术的死亡率和并发症发生率较低;然而,再次手术率较高,体重减轻量小于胃旁路术。胃袖状切除术在减轻体重方面似乎比可调胃束带术更有效,与胃旁路术相当。
减重手术对大多数减重患者的体重减轻和改善肥胖相关合并症具有显著且持续的效果,但存在并发症、再次手术和死亡的风险。死亡率低于以前的荟萃分析报告的死亡率。